US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist

2.325
+0.015+0.65%

Trading Nov 22 11:59 ET

139.69MMarket Cap-1684P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-90.59%-24.6M

-41.77%-16.55M

-75.52%-17.86M

-22.50%-43.06M

25.79%-8.31M

-40.53%-12.91M

-80.43%-11.67M

-22.61%-10.18M

-95.72%-35.15M

-207.86%-11.2M

Net income from continuing operations

-129.72%-29.77M

-76.89%-20.54M

-31.54%-14.87M

-22.20%-52.37M

-28.22%-16.5M

-20.98%-12.96M

-14.37%-11.61M

-23.86%-11.31M

57.40%-42.86M

-54.10%-12.87M

Operating gains losses

---85K

---1.1M

--48K

--1.35M

----

Depreciation and amortization

12.50%45K

-15.09%45K

-15.38%44K

8.88%184K

-20.41%39K

-9.09%40K

35.90%53K

40.54%52K

4,125.00%169K

1,533.33%49K

Other non cash items

--514K

--271K

--268K

--884K

----

Change In working capital

525.28%3.73M

382.23%3.77M

-17,045.83%-4.07M

-3.01%3.87M

643.73%6.05M

-294.25%-878K

-148.32%-1.33M

158.54%24K

1,237.58%3.99M

-80.01%814K

-Change in prepaid assets

-156.51%-846K

-202.13%-3.12M

74.86%-226K

-121.71%-369K

118.72%67K

222.30%1.5M

-155.41%-1.03M

-163.49%-899K

143.80%1.7M

-186.06%-358K

-Change in payables and accrued expense

292.31%4.55M

2,895.18%6.96M

-481.29%-3.83M

71.80%4.4M

373.90%6.01M

-239.56%-2.37M

-126.05%-249K

173.90%1.01M

-38.95%2.56M

-65.33%1.27M

-Change in other current assets

205.26%58K

-223.08%-42K

179.55%35K

48.91%-70K

45.76%-32K

35.71%19K

51.85%-13K

32.31%-44K

-878.57%-137K

-5,800.00%-59K

-Change in other current liabilities

-11.11%-30K

23.68%-29K

-15.79%-44K

32.12%-93K

127.03%10K

20.59%-27K

-11.76%-38K

-18.75%-38K

---137K

---37K

Cash from discontinued investing activities

Operating cash flow

-90.59%-24.6M

-41.77%-16.55M

-75.52%-17.86M

-22.50%-43.06M

25.79%-8.31M

-40.53%-12.91M

-80.43%-11.67M

-22.61%-10.18M

-95.72%-35.15M

-207.86%-11.2M

Investing cash flow

Cash flow from continuing investing activities

88.99%-10.13M

240.74%37.7M

78.05%-9.2M

-538.10%-171.67M

-139.02%-48.81M

-264.53%-92M

25.94%11.06M

-722.26%-41.93M

137.63%39.19M

-103.98%-20.42M

Net PPE purchase and sale

--0

---5K

---11K

88.82%-18K

60.00%-14K

95.06%-4K

--0

-302.50%-161K

-34.62%-35K

Net investment purchase and sale

88.99%-10.13M

240.78%37.7M

78.08%-9.19M

-536.27%-171.65M

-139.36%-48.79M

-264.28%-92M

25.43%11.06M

-723.71%-41.93M

137.80%39.35M

-104.16%-20.39M

Cash from discontinued investing activities

Investing cash flow

88.99%-10.13M

240.74%37.7M

78.05%-9.2M

-538.10%-171.67M

-139.02%-48.81M

-264.53%-92M

25.94%11.06M

-722.26%-41.93M

137.63%39.19M

-103.98%-20.42M

Financing cash flow

Cash flow from continuing financing activities

-100.03%-42K

11.72%-128K

7.11M

3,784.13%151.75M

596.32%29.13M

46,778.33%122.76M

-145K

-98.05%3.91M

41,740.00%4.18M

Net issuance payments of debt

--0

---739K

--30M

--0

----

Net common stock issuance

--0

--7.91M

3,114.77%121.9M

-110.28%-390K

--122.29M

--0

-97.75%3.79M

126,500.00%3.79M

Proceeds from stock option exercised by employees

----

182.61%325K

--0

----

-93.88%115K

638.46%96K

Net other financing activities

---42K

---128K

---60K

---476K

----

Cash from discontinued financing activities

Financing cash flow

-100.03%-42K

11.72%-128K

--7.11M

3,784.13%151.75M

596.32%29.13M

46,778.33%122.76M

---145K

--0

-98.05%3.91M

41,740.00%4.18M

Net cash flow

Beginning cash position

-11.73%68.19M

-39.53%47.16M

-48.41%67.12M

6.50%130.1M

-39.63%95.11M

-30.45%77.25M

-28.29%78M

6.50%130.1M

179.06%122.16M

16.01%157.54M

Current changes in cash

-294.70%-34.77M

2,899.73%21.03M

61.70%-19.96M

-893.32%-62.98M

-2.00%-27.99M

-61.57%17.86M

-132.61%-751K

-288.88%-52.1M

-89.87%7.94M

-101.17%-27.44M

End cash Position

-64.86%33.42M

-11.73%68.19M

-39.53%47.16M

-48.41%67.12M

-39.63%95.11M

-30.45%77.25M

-28.29%78M

6.50%130.1M

Free cash flow

-90.49%-24.6M

-41.82%-16.55M

-75.63%-17.87M

-22.01%-43.09M

25.89%-8.33M

-39.38%-12.91M

-79.43%-11.67M

-22.47%-10.18M

-96.18%-35.31M

-206.63%-11.24M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-90.59%-24.6M	-41.77%-16.55M	-75.52%-17.86M	-22.50%-43.06M	25.79%-8.31M	-40.53%-12.91M	-80.43%-11.67M	-22.61%-10.18M	-95.72%-35.15M	-207.86%-11.2M
Net income from continuing operations	-129.72%-29.77M	-76.89%-20.54M	-31.54%-14.87M	-22.20%-52.37M	-28.22%-16.5M	-20.98%-12.96M	-14.37%-11.61M	-23.86%-11.31M	57.40%-42.86M	-54.10%-12.87M
Operating gains losses	---85K	---1.1M	--48K	--1.35M	----	----	----	----	----	----
Depreciation and amortization	12.50%45K	-15.09%45K	-15.38%44K	8.88%184K	-20.41%39K	-9.09%40K	35.90%53K	40.54%52K	4,125.00%169K	1,533.33%49K
Other non cash items	--514K	--271K	--268K	--884K	----	----	----	----	----	----
Change In working capital	525.28%3.73M	382.23%3.77M	-17,045.83%-4.07M	-3.01%3.87M	643.73%6.05M	-294.25%-878K	-148.32%-1.33M	158.54%24K	1,237.58%3.99M	-80.01%814K
-Change in prepaid assets	-156.51%-846K	-202.13%-3.12M	74.86%-226K	-121.71%-369K	118.72%67K	222.30%1.5M	-155.41%-1.03M	-163.49%-899K	143.80%1.7M	-186.06%-358K
-Change in payables and accrued expense	292.31%4.55M	2,895.18%6.96M	-481.29%-3.83M	71.80%4.4M	373.90%6.01M	-239.56%-2.37M	-126.05%-249K	173.90%1.01M	-38.95%2.56M	-65.33%1.27M
-Change in other current assets	205.26%58K	-223.08%-42K	179.55%35K	48.91%-70K	45.76%-32K	35.71%19K	51.85%-13K	32.31%-44K	-878.57%-137K	-5,800.00%-59K
-Change in other current liabilities	-11.11%-30K	23.68%-29K	-15.79%-44K	32.12%-93K	127.03%10K	20.59%-27K	-11.76%-38K	-18.75%-38K	---137K	---37K
Cash from discontinued investing activities
Operating cash flow	-90.59%-24.6M	-41.77%-16.55M	-75.52%-17.86M	-22.50%-43.06M	25.79%-8.31M	-40.53%-12.91M	-80.43%-11.67M	-22.61%-10.18M	-95.72%-35.15M	-207.86%-11.2M
Investing cash flow
Cash flow from continuing investing activities	88.99%-10.13M	240.74%37.7M	78.05%-9.2M	-538.10%-171.67M	-139.02%-48.81M	-264.53%-92M	25.94%11.06M	-722.26%-41.93M	137.63%39.19M	-103.98%-20.42M
Net PPE purchase and sale	--0	---5K	---11K	88.82%-18K	60.00%-14K	95.06%-4K	--0	--0	-302.50%-161K	-34.62%-35K
Net investment purchase and sale	88.99%-10.13M	240.78%37.7M	78.08%-9.19M	-536.27%-171.65M	-139.36%-48.79M	-264.28%-92M	25.43%11.06M	-723.71%-41.93M	137.80%39.35M	-104.16%-20.39M
Cash from discontinued investing activities
Investing cash flow	88.99%-10.13M	240.74%37.7M	78.05%-9.2M	-538.10%-171.67M	-139.02%-48.81M	-264.53%-92M	25.94%11.06M	-722.26%-41.93M	137.63%39.19M	-103.98%-20.42M
Financing cash flow
Cash flow from continuing financing activities	-100.03%-42K	11.72%-128K	7.11M	3,784.13%151.75M	596.32%29.13M	46,778.33%122.76M	-145K	0	-98.05%3.91M	41,740.00%4.18M
Net issuance payments of debt	--0	--0	---739K	--30M	--30M	--0	--0	--0	--0	----
Net common stock issuance	--0	--0	--7.91M	3,114.77%121.9M	-110.28%-390K	--122.29M	--0	--0	-97.75%3.79M	126,500.00%3.79M
Proceeds from stock option exercised by employees	----	----	----	182.61%325K	--0	----	----	----	-93.88%115K	638.46%96K
Net other financing activities	---42K	---128K	---60K	---476K	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-100.03%-42K	11.72%-128K	--7.11M	3,784.13%151.75M	596.32%29.13M	46,778.33%122.76M	---145K	--0	-98.05%3.91M	41,740.00%4.18M
Net cash flow
Beginning cash position	-11.73%68.19M	-39.53%47.16M	-48.41%67.12M	6.50%130.1M	-39.63%95.11M	-30.45%77.25M	-28.29%78M	6.50%130.1M	179.06%122.16M	16.01%157.54M
Current changes in cash	-294.70%-34.77M	2,899.73%21.03M	61.70%-19.96M	-893.32%-62.98M	-2.00%-27.99M	-61.57%17.86M	-132.61%-751K	-288.88%-52.1M	-89.87%7.94M	-101.17%-27.44M
End cash Position	-64.86%33.42M	-11.73%68.19M	-39.53%47.16M	-48.41%67.12M	-48.41%67.12M	-39.63%95.11M	-30.45%77.25M	-28.29%78M	6.50%130.1M	6.50%130.1M
Free cash flow	-90.49%-24.6M	-41.82%-16.55M	-75.63%-17.87M	-22.01%-43.09M	25.89%-8.33M	-39.38%-12.91M	-79.43%-11.67M	-22.47%-10.18M	-96.18%-35.31M	-206.63%-11.24M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data